Viewing Study NCT04643002


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2025-12-26 @ 2:56 AM
Study NCT ID: NCT04643002
Status: RECRUITING
Last Update Posted: 2025-08-11
First Post: 2020-10-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-01-25
Start Date Type: ACTUAL
Primary Completion Date: 2027-09-13
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-04-20
Completion Date Type: ESTIMATED
First Submit Date: 2020-10-20
First Submit QC Date: None
Study First Post Date: 2020-11-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-08
Last Update Post Date: 2025-08-11
Last Update Post Date Type: ACTUAL